Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KPNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYO5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP104 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IVNS1ABP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929612 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAD2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM208A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on